Key financial ranges
Market cap · USD equivalent
P/E ratio
Annual revenue · USD equivalent
Revenue growth
Valuation & profitability
Price / sales
Annual net income · USD equivalent
Net profit margin
Cash & debt
Cash · USD equivalent
Total debt · USD equivalent
Net cash · USD equivalent
Debt / revenue
| Company | Market cap | P/E | Revenue | Rev. growth | Net income | Cash | Debt | AI value |
|---|---|---|---|---|---|---|---|---|
| BCRXBiocryst Pharmaceuticals Inc | $2.53B | — | $874.84M | +94.1% | $263.86M | $154.97M | $409.86M | Fair valued |
| DCODucommun Inc | $2.53B | — | $824.84M | +4.9% | -$37.35M | $39.8M | $335.87M | Fair valued |
| PHINPhinia Inc. | $2.53B | 19.8× | $3.48B | +2.4% | $130M | $370M | $1.07B | Undervalued |
| PHVSPharvaris N.V. | $2.54B | — | — | — | — | €291.68M | €776.8K | Fair valued |
| INTRInter & Co, Inc. | $2.54B | 8.8× | R$6.4B | +34.7% | R$972.84M | R$1.11B | R$242.61M | Undervalued |
| PGENPrecigen, Inc. | $2.55B | — | $9.68M | +146.7% | -$250.64M | $16.33M | $98.35M | Fair valued |
| SAHSonic Automotive Inc | $2.55B | 12.9× | $15.15B | +6.5% | $118.7M | $19.2M | $2.43B | Fair valued |
| SKWDSkyward Specialty Insurance Group, Inc. | $2.55B | 13.4× | $12.38M | +16.0% | $170.03M | $219.22M | $3.21M | AI pending |
| SUPNSupernus Pharmaceuticals, Inc. | $2.55B | — | $718.95M | +8.6% | -$38.55M | $179.95M | $40.17M | AI pending |
| CURLFCuraleaf Holdings, Inc. | $2.55B | — | $1.27B | -5.0% | -$231.07M | $94.59M | $909.21M | Overvalued |
| IVTInvenTrust Properties Corp. | $2.55B | 168.7× | $299.17M | +9.2% | $111.42M | $74.9M | $1.1B | AI pending |
| WGSGeneDx Holdings Corp. | $2.56B | — | $427.54M | +40.0% | -$21.02M | $60.32M | $96.84M | AI pending |
| AXGNAxogen, Inc. | $2.56B | — | $225.21M | +20.2% | -$15.7M | $94.57M | $20.07M | AI pending |
| GRDNGuardian Pharmacy Services, Inc. | $2.56B | 39.0× | $1.45B | +17.9% | $49.22M | $89.81M | $35.24M | AI pending |
| VERAVera Therapeutics, Inc. | $2.56B | — | — | — | — | $48.88M | $75.23M | AI pending |
| NEOGNeogen Corp | $2.57B | — | $870.4M | -2.7% | -$7.9M | $185.5M | $812.7M | AI pending |
| OUSTOuster, Inc. | $2.58B | — | $169.38M | +52.5% | -$60.38M | $91.76M | $16.4M | AI pending |
| VRDNViridian Therapeutics, Inc.\DE | $2.58B | — | $70.85M | +23,359.9% | -$342.6M | $164.99M | $722K | AI pending |
| BHEBenchmark Electronics Inc | $2.58B | 49.1× | $2.75B | -0.4% | $24.85M | $314.84M | $287.98M | AI pending |
| CDNACareDx, Inc. | $2.58B | 24.1× | $379.81M | +13.8% | -$21.35M | $373.64M | $19.25M | AI pending |